Description of Collaborative Activity: |
The working group is charged with designing and coordinating research studies to evaluate whether xenotropic murine leukemia virus-related virus (XMRV) poses a threat to blood safety. The group is led by the NHLBI and includes representatives from the PHS, the FDA, and the CDC, as well as experts in research on transfusion medicine, blood banking, retrovirology, and myalgic encephalopathy/chronic fatigue syndrome. |
